061250 Stock Chart & Stats
₩8750.00
₩50.00(0.57%)
―
--
Day’s Range― - ―
52-Week Range₩7,090.00 - ₩13,800.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)15.65K
Market Cap
₩52.87B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)71.9
Beta0.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding8,417,584
10 Day Avg. Volume10,769
30 Day Avg. Volume15,654
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
061250 FAQ
What was Hwail Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Hwail Pharmaceutical Co., Ltd. lowest stock price was ₩7090.00 and its highest was ₩13800.00 in the past 12 months.
What is Hwail Pharmaceutical Co., Ltd.’s market cap?
Hwail Pharmaceutical Co., Ltd.’s market cap is ₩52.87B.
When is Hwail Pharmaceutical Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Hwail Pharmaceutical Co., Ltd.’s earnings last quarter?
Hwail Pharmaceutical Co., Ltd. released its earnings results on May 15, 2026. The company reported ₩68.784 earnings per share for the quarter, beating the consensus estimate of N/A by ₩68.784.
Is Hwail Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Hwail Pharmaceutical Co., Ltd.’s price is currently Undervalued.
Does Hwail Pharmaceutical Co., Ltd. pay dividends?
Hwail Pharmaceutical Co., Ltd. does not currently pay dividends.
What is Hwail Pharmaceutical Co., Ltd.’s EPS estimate?
Hwail Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hwail Pharmaceutical Co., Ltd. have?
Hwail Pharmaceutical Co., Ltd. has 8,417,584 shares outstanding.
What happened to Hwail Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Hwail Pharmaceutical Co., Ltd. reported an EPS of ₩68.784 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.594%.
Which hedge fund is a major shareholder of Hwail Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in KR:061250
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Yuyu Pharma, Inc.
―
Jin Yang Pharmaceutical Co., Ltd.
―
Samik Pharm Co., Ltd.
―
Aptamer Sciences, Inc.
―
J2KBIO Co., Ltd.
―